-
L-thyroxine impact on bone mineral density in primary
hypothyroidism
-
Bone
density changes in spinal-cord injured patients
-
Bone
density changes in stroke patients
-
A phase III
study of intermittent cyclical Tiludronate in the treatment of established post-menopausal
osteoporosis
-
A randomized, double-blind, placebo-controlled,
multi-center, parallel group study to determine the efficacy and safety of
risedronate (NE-58095) in the treatment of post menopausal
women with established osteoporosis-related vertebral deformities
-
A four-year (three-year core and one-year partial
crossover), double-blind, multi-center, placebo-controlled study of the
effects of three different doses of Calcimar (synthetic salmon
calcitonin, injectable) on bone mineral density, stature, and
biochemical markers of bone turnover in women with established
postmenopausal osteoporosis.
-
Change of bone density during pregnancy and lactation
-
The use of
computed tomography for measurement of
bone density to distinguish fractures of osteogenesis imperfecta from
child abuse
-
A randomized, comparative multi-center clinical trial
evaluating Norian SRS and conventional treatment in unstable
metaphyseal fractures of the distal radius
-
Disuse
osteoporosis : changes in biochemical
parameters during and following simulated micro-gravity
-
Measurement of
bone density changes in simulated micro-gravity using an enhanced gamma computed
tomography device
-
Qualification of radiologic technologists in North America for the
test-retest reliability of measurements of the tibiofemoral joint
space width in subjects with osteoarthritis of the knee
-
Radiographic knee procedures for clinical study in knee
osteoarthritis
-
A randomized, double blind, parallel, multi-center,
placebo-controlled, two year study to determine the efficacy and
safety of orally administered 5 and 15 mg/day, and 50 mg/week
risedronate in patients with medial compartment knee osteoarthritis in
North America
-
A
randomized, double-blind, multicenter study to evaluate the
tolerability and effectiveness of etoricoxib 90 mg q.d. versus
diclofenac sodium 75 mg b.i.d. in patients with rheumatoid arthritis
-
A
randomized, double-blind, placebo-controlled, multicenter,
parallel-group study of one-year duration followed by 2 years of
open-label treatment to determine the safety and efficacy of orally
administered 2.5 mg or 5.0 mg risedronate in children > 4 to <
16 years old with osteogenesis imperfecta
